Human papillomavirus infection in non-neoplastic uterine cervical disease in Hong Kong

British Journal of Biomedical Science

Volumn 58, Issue 2, 2001, Pages 85-91

  Lee, Christina N Y ^a   Cavanagh, Heather M A ^c   Lo, Stephen T H ^b   Ng, Chi Sing ^b  

^a UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^b Caritas Medical Centre Hong Kong   (Hong Kong)

^c NONE

Author keywords

Cervix uteri; Papillomavirus, human; Polymerase chain reaction; Population surveillance

Indexed keywords

ARTICLE; CANCER SCREENING; GENE TARGETING; HIGH RISK PATIENT; HISTOPATHOLOGY; HONG KONG; HUMAN; HUMAN TISSUE; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX DISEASE; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; FEMALE; HONG KONG; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DISEASES;

EID: 0034972235     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. WHO Databank, 1997. 〈http://www-dep.iarc.fr/cgi-bin/cgisql/who2.idc〉.
2. Wright TC Jr, Richart RM. Role of human papillomavirus in the pathogenesis of genital tract warts and cancer. Gynecol Oncol 1990;37: 151-64.
3. Syrjanen KJ. Human papillomavirus in genital carcinogenesis. Sex Transm Dis 1994; 21(Suppl2): S86-9.
4. Franco EL. Epidemiology of anogenital warts and cancer. Obstet Gynecol Clinic North Am 1996; 23: 597-623.
5. Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1996; 1288: F55-78.
6. Bosch FX, Manos MM, Munoz, N et at. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87: 796-802.
7. Schiffman MH, Bauer HM, Lorincz, AT et al. Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J Clin Microbiol 1991; 29: 573-7.
8. Guerrero E, Daniel RW, Xavier Bosch F et al. Comparison of ViraPap, Southern hybridization and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol 1992; 30: 2951-9.
9. Manos MM, Ting Y, Wright DK et al. Use of the polymerase chain reaction amplification for the detection of genital human papillomavirus. In: Cancer cells: molecular diagnostics of human cancer. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989; 7: 209-14.
10. Snijders PJF, van den Brule AJC, Maine MD et al. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 1990; 71: 173-81.
11. van den Brule AJC, Walboomers JMM, Maine MD et al. Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears in associated with a history of cervical intraepithelial neoplasia. Int J Cancer 1991; 48: 404-8.
12. Chan MKM, Lau KM, Tsui Y et al. Human papillomavirus infection in Hong Kong Chinese women with normal and abnormal cervix - detection by polymerase chain reaction method on cervical scrapes. Gynec Oncol 1996; 60: 217-23.
13. Saiki RK, Scharf S, Faloona F et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350-4.
14. Wong NK, Chan YF, The incidence of abnormal cervical smears in routine screening in female Hong Kong Chinese, HK Pract 1990; 12: 731-9.
15. Hsu C, Ho SC, Tang SK et al. Human papillomavirus infection of the uterine cervix in Hong Kong: a cytological survey. J HK Med Ass 1991; 43: 7-9.
16. Lorincz AT. Molecular methods for the detection of human papillomavirus infection. Obstet Gynecol Clin North Am 1996; 23: 707-30.
17. Bauer HM, Ting Y, Greer CE et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991; 265: 472-7.
18. Greer CE, Peterson SL, Kiviat NB et al. PCR amplification from paraffin-embedded tissues. Effects of fixative and fixation time. Am J Clin Pathol 1991; 95: 117-24.
19. Nash T, Burke T, Hoskins W. Biologic course of cervical human papillomavirus infection. Obstet Gynecol 1987; 69: 160-2.
20. Matsuura Y, Kawagoe T, Toki N, Sugihara K, Kashimura M. Low-grade cervical intraepithelial neoplasia associated with human papillomavirus infection: long-term follow-up. Acta Cytol 1998; 42: 625-30.
21. Ho GYF, Bierman MD, Beardsley L et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-8.
22. Falcinelli C, van Belkum A, Schrauwen L, Seldenrijk K, Quint WG. Absence of human papillomavirus type 16 E6 transcripts in HPV 16-infected, cytologically normal cervical scrapings. J Med Virol 1993; 40: 261-5.
23. Selinka HC, Sotlar K, Lingel K, Sauter M, Kandolf R, Bultmann B. Detection of human papillomavirus 16 transcriptional activity in cervical intraepithelial neoplasia grade III lesions and cervical carinomas by nested reverse transcription-polymerase chain reaction and in situ hybridization. Lab Invest 1998; 78: 9-18.
24. th Annual Scientific Meeting of the Hong Kong Division of the International Academy of Pathology 1998: 13.
25. McMeekin DS, McGonigle KF, Vasilev SA. Cervical cancer prevention: toward cost-effective screening, 〈http://www. medscape.com/Medscape/women.hjK02.n12/wh3023.vasilev/wh3023, vasilev.html〉.
26. Herrington CS, Evans MF, Charnock FM, Gray W, O'D McGee J. HPV testing in patients with low-grade cervical cytological abnormalities: a follow-up study. J Clin Path 1996; 49: 493-6.
27. Wagner JL. Cost-effectiveness of screening for common cancers. Cancer Metast Rev 1997; 16; 281-94.
28. Morrison EA, Ho GY, Vermund SH et al. Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Int J Cancer 1991; 49: 6-13.
29. de Sanjose S, Santamaria M, Alonso de Ruiz P et al. HPV types in women with normal cervical cytology. IARC Sci Publ 1992; 119: 75-84.
30. van Ballegooijen M, van den Akker-van Marle ME, Warmerdam PG, Walboomers JM, Habbema JD. Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the cost-effectiveness. Br J Cancer 1997; 76: 651-7.
31. Meijer CJLM, Helmerhorst TJM, Rozendaal L et al. HPV typing and testing in gynaecological pathology: has the time come? Histopathology 1998; 33: 83-6.